Investigational Site Number : 124004

Montreal, Quebec H3A2B4

1 studies enrolling now · 2 studies all time

What they study most

Glycogen Storage Disease Type II, Pompe Disease, Prostate Cancer Metastatic

Studies at this site

• Pompe Disease Registry Protocol — Recruiting now
• Early Switch From First-Line Docetaxel/Prednisone to Cabazitaxel/Prednisone and the Opposite Sequence, Exploring Molecular Markers in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC) — Completed